Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program

A.J. van den Eertwegh; P. Karakiewicz; S. Bavbek; S.Y. Rha; S. Bracarda; A. Bahl; Y.C. Ou; D. Kim; A. Panneerselvam; O. Anak; V. Grunwald

doi:10.1016/j.urology.2012.09.019

Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program

A.J. van den Eertwegh, P. Karakiewicz, S. Bavbek, S.Y. Rha, S. Bracarda, A. Bahl, Y.C. Ou, D. Kim, A. Panneerselvam, O. Anak, V. Grunwald

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	143-149
Journal	Urology
Volume	81
Issue number	1
DOIs	https://doi.org/10.1016/j.urology.2012.09.019
Publication status	Published - 2013

Access to Document

10.1016/j.urology.2012.09.019

Cite this

@article{a44dbf596e5a4051b6b29e964a3b89b9,

title = "Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program",

author = "{van den Eertwegh}, A.J. and P. Karakiewicz and S. Bavbek and S.Y. Rha and S. Bracarda and A. Bahl and Y.C. Ou and D. Kim and A. Panneerselvam and O. Anak and V. Grunwald",

year = "2013",

doi = "10.1016/j.urology.2012.09.019",

language = "Undefined/Unknown",

volume = "81",

pages = "143--149",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program

AU - van den Eertwegh, A.J.

AU - Karakiewicz, P.

AU - Bavbek, S.

AU - Rha, S.Y.

AU - Bracarda, S.

AU - Bahl, A.

AU - Ou, Y.C.

AU - Kim, D.

AU - Panneerselvam, A.

AU - Anak, O.

AU - Grunwald, V.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.urology.2012.09.019

DO - 10.1016/j.urology.2012.09.019

M3 - Article

C2 - 23273080

VL - 81

SP - 143

EP - 149

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -